Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | |
---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||
Cash from operating activities | -13.60%1.02B | 122.22%1.18B | -31.61%532.51M | 778.67M |
Net profit before non-cash adjustment | 1.06%972.11M | 45.23%961.88M | 1.72%662.3M | --651.1M |
Total adjustment of non-cash items | -11.04%142.02M | 32.11%159.64M | 73.89%120.84M | --69.49M |
-Depreciation and amortization | 8.64%128.9M | 7.24%118.65M | 9.89%110.64M | --100.68M |
-Reversal of impairment losses recognized in profit and loss | --0 | -45.39%8.74M | --16M | --0 |
-Disposal profit | -113.77%-2.34M | 147.87%17.01M | 711.68%6.86M | ---1.12M |
-Other non-cash items | 1.44%15.46M | 220.35%15.24M | 57.87%-12.67M | ---30.07M |
Changes in working capital | -248.29%-91.7M | 124.67%61.84M | -531.48%-250.63M | --58.09M |
-Change in receivables | 61.26%-23.68M | -139.79%-61.13M | -491.33%-25.5M | --6.52M |
-Change in inventory | -285.26%-96.39M | 118.92%52.03M | -5,436.45%-275.05M | ---4.97M |
-Change in prepaid assets | 84.58%59.02M | 162.34%31.97M | 216.99%12.19M | ---10.42M |
-Change in payables | 300.86%31.48M | -345.10%-15.67M | -68.47%6.4M | --20.28M |
-Provision for loans, leases and other losses | 43.46%8.23M | -71.78%5.73M | 191.95%20.32M | --6.96M |
-Changes in other current assets | -243.85%-70.36M | 344.00%48.91M | -72.26%11.02M | --39.72M |
Dividends paid (cash flow from operating activities) | ||||
Dividends received (cash flow from operating activities) | ||||
Interest paid (cash flow from operating activities) | -2.67%-18.18M | 2.54%-17.71M | -11.64%-18.17M | -16.27M |
Interest received (cash flow from operating activities) | 59.56%2.56M | 1.90%1.61M | 2,400.00%1.58M | 63K |
Tax refund paid | -3.55%-286.08M | -20.44%-276.28M | -7.87%-229.39M | -212.65M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 |
Operating cash flow | -19.11%720.73M | 210.95%890.98M | -47.89%286.53M | --549.81M |
Investing cash flow | ||||
Net PPE purchase and sale | -281.05%-388.46M | 79.25%-101.95M | -20.83%-491.37M | ---406.66M |
Net business purchase and sale | ---- | ---- | ---255M | --0 |
Net investment product transactions | -450.85%-57.66M | -1,736.32%-10.47M | -101.05%-570K | --54.27M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | --31K |
Net changes in other investments | -48.45%-24.18M | 9.53%-16.29M | -40.97%-18.01M | ---12.77M |
Investing cash flow | -265.42%-470.3M | 83.18%-128.7M | -109.50%-764.95M | ---365.13M |
Financing cash flow | ||||
Net issuance payments of debt | 113.77%30.43M | -135.74%-220.96M | 733.11%618.17M | ---97.64M |
Net common stock issuance | -68.42%91.8M | --290.72M | --0 | ---- |
Cash dividends paid | -71.64%-237.3M | -12.82%-138.26M | -5.41%-122.55M | ---116.26M |
Net other fund-raising expenses | ---- | ---- | --360M | ---- |
Financing cash flow | -68.00%-115.07M | -108.01%-68.49M | 500.01%855.63M | ---213.9M |
Net cash flow | ||||
Beginning cash position | 20.91%4.01B | 12.89%3.32B | -0.95%2.94B | --2.97B |
Current changes in cash | -80.49%135.36M | 83.93%693.78M | 1,391.15%377.21M | ---29.22M |
Effect of exchange rate changes | 710.31%786K | -94.27%97K | 90.65%1.69M | --888K |
Cash adjustments other than cash changes | 0.00%-1K | -200.00%-1K | --1K | ---- |
End cash Position | 3.39%4.15B | 20.91%4.01B | 12.89%3.32B | --2.94B |
Free cash flow | -57.86%332.27M | 476.34%788.55M | -249.25%-209.53M | --140.39M |
Currency Unit | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |